Onderzoeker
Elisabeth De Leeuw
- Trefwoorden (Ghent University):Astma, antivirale immuniteit
- Disciplines (Flanders Institute for Biotechnology):Analyse van next-generation sequence data, Adaptieve immunologie, Bacteriologie
- Disciplines (Ghent University):Toegepaste immunologie
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2019 → Heden - Lambrecht and Hammad Lab (Onderzoeksgroep)
Lid
Vanaf1 okt 2019 → Heden
Projecten
1 - 1 of 1
- Hoe induceert neonatale pneumovirus infectie een verhoogd risico op astma?Vanaf1 nov 2021 → HedenFinanciering: FWO mandaten
Publicaties
1 - 10 van 11
- Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection : from prognostic marker to therapeutic agent(2022)
Auteurs: Elisabeth De Leeuw
- Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial(2022)
Auteurs: Elisabeth De Leeuw, Karel Van Damme, Jozefien Declercq, Cédric Bosteels, Bastiaan Maes, Simon Tavernier, Laurent Detalle, Trevor Smart, Sophie Glatt, Nincy Debeuf, et al.
- Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment(2022)
Auteurs: Cédric Bosteels, Karel Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Victor Bosteels, Levi Hoste, Leslie Naesens, Basiel Cole, Marion Pardons, Daniela Weiskopf, et al.
- Isolation of conventional murine lung dendritic cell subsets(2022)Series: Methods in molecular biology
Auteurs: Elisabeth De Leeuw, Cédric Bosteels, Bart Lambrecht, Hamida Hammad
Pagina's: 237 - 255 - TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C(2022)
Auteurs: Levi Hoste, Lisa Roels, Leslie Naesens, Victor Bosteels, Stijn Vanhee, Sam Dupont, Cédric Bosteels, Robin Browaeys, Niels Vandamme, Kevin Verstaen, et al.
- Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19 : a meta-analysis(2021)
Auteurs: [missing] The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Isabel Mur, Gracia María Mateo, Maria del Mar Gutierrez, Virginia Pomar, Natividad de Benito, Noemí Corbacho, Silvia Herrera, Lucia Millan, Jessica Muñoz, et al.
Pagina's: 499 - 518 - Case report : convalescent plasma, a targeted therapy for patients with CVID and severe COVID-19(2020)
Auteurs: Karel Van Damme, Elisabeth De Leeuw, Cédric Bosteels, Bastiaan Maes, Marieke De Bruyne, Delfien Bogaert, Victor Bosteels, Levi Hoste, Leslie Naesens, P Maes, et al.
- Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV) : a structured summary of a study protocol for a randomised controlled trial(2020)
Auteurs: Cédric Bosteels, Karel Van Damme, Elisabeth De Leeuw, Bastiaan Maes, Ans Vandecauter, Stefanie Vermeersch, Anja Delporte, Bénédicte Demeyere, Marnik Vuylsteke, Marianna Lalla, et al.
- Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID) : a structured summary of a study protocol for a randomised controlled trial (vol 21, 468, 2020)
Auteurs: Bastiaan Maes, Cédric Bosteels, Elisabeth De Leeuw, Karel Van Damme, Anja Delporte, Benedicte Demeyere, Stefanie Vermeersch, Marnik Vuylsteke, Joren Willaert, Laura Bollé, et al.
- Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC) : a structured summary of a study protocol for a randomised controlled trial (vol 21, 491, 2020)
Auteurs: Cédric Bosteels, Bastiaan Maes, Karel Van Damme, Elisabeth De Leeuw, Anja Delporte, Benedicte Demeyere, Stefanie Vermeersch, Marnik Vuylsteke, Joren Willaert, Laura Bollé, et al.